Literature DB >> 2451463

The relative merits of acute phase proteins in the recognition of inflammatory conditions.

J Calvin1, G Neale, K J Fotherby, C P Price.   

Abstract

A study has been undertaken on the relative merits of a variety of acute phase proteins in the assessment of patients with inflammatory conditions. Five acute phase proteins (alpha 1-antitrypsin, alpha 1-antichymotrypsin, orosomucoid, haptoglobin and C-reactive protein) and the ESR were measured in 171 patients presenting to the gastroenterologists (gastrointestinal disease: 130, other disease: 41). Assessment of the sensitivity and specificity of the proteins and the ESR showed alpha 1-antichymotrypsin to be the most sensitive test (95%) with specificity (81%) similar to the other acute phase proteins measured. Factors such as oestrogens, renal failure and genetic variants affected the value of alpha 1-antitrypsin, orosomucoid and haptoglobin. In the routine protein laboratory the combination of a 'short' half-life and 'long' half-life protein is likely to offer the most useful screen for inflammation in samples obtained from a wide range of patients. The two acute phase proteins C-reactive protein and alpha 1-antichymotrypsin fulfil these criteria.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2451463     DOI: 10.1177/000456328802500108

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  8 in total

1.  Vitamin B12 supplementation during pregnancy and postpartum improves B12 status of both mothers and infants but vaccine response in mothers only: a randomized clinical trial in Bangladesh.

Authors:  Towfida J Siddiqua; Shaikh M Ahmad; Khalid B Ahsan; Mamunur Rashid; Anjan Roy; Syed M Rahman; Setareh Shahab-Ferdows; Daniela Hampel; Tahmeed Ahmed; Lindsay H Allen; Rubhana Raqib
Journal:  Eur J Nutr       Date:  2015-02-04       Impact factor: 5.614

2.  Plasma viscosity and erythrocyte sedimentation rate in inflammatory and non-inflammatory rheumatic disorders.

Authors:  G J Dinant; J W van Wersch; H S Goei The; J A Knottnerus
Journal:  Clin Rheumatol       Date:  1992-03       Impact factor: 2.980

3.  The use of adjustment factors to address the impact of inflammation on vitamin A and iron status in humans.

Authors:  David I Thurnham; Christine A Northrop-Clewes; Jacqueline Knowles
Journal:  J Nutr       Date:  2015-04-01       Impact factor: 4.798

4.  Evidence for a Role of Nerve Injury in Painful Intervertebral Disc Degeneration: A Cross-Sectional Proteomic Analysis of Human Cerebrospinal Fluid.

Authors:  Tony K Y Lim; Kathleen M Anderson; Pawan Hari; Marcos Di Falco; Troy E Reihsen; George L Wilcox; Kumar G Belani; Sylvie LaBoissiere; Manuel R Pinto; David S Beebe; Lois J Kehl; Laura S Stone
Journal:  J Pain       Date:  2017-06-24       Impact factor: 5.820

5.  Association of alpha(1)-antichymotrypsin deficiency with milder lung disease in patients with cystic fibrosis.

Authors:  R Mahadeva; L Sharples; R I Ross-Russell; A K Webb; D Bilton; D A Lomas
Journal:  Thorax       Date:  2001-01       Impact factor: 9.139

6.  Serum alpha 1 antichymotrypsin concentration as a marker of disease activity in rheumatoid arthritis.

Authors:  M D Chard; J Calvin; C P Price; T E Cawston; B L Hazleman
Journal:  Ann Rheum Dis       Date:  1988-08       Impact factor: 19.103

7.  Acute normovolaemic haemodilution does not reduce the inflammatory process induced by facial surgery.

Authors:  D Peillon; J Dubost; J Bienvenu; P Y Carry; C Roche; P Breton; M Freidel; V Banssillon
Journal:  Can J Anaesth       Date:  1995-04       Impact factor: 5.063

8.  Agalactosyl IgG in inflammatory bowel disease: correlation with C-reactive protein.

Authors:  R Dubé; G A Rook; J Steele; R Brealey; R Dwek; T Rademacher; J Lennard-Jones
Journal:  Gut       Date:  1990-04       Impact factor: 23.059

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.